12:00 AM
 | 
Apr 13, 2009
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Catena Pharmaceuticals Inc.

Durham, N.C.

Technology: Chemistry to develop compounds that block lysophosphatidic acid (LPA) signaling

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >